Gleiss Lutz advised DiosCURE Therapeutics on the deal. In the seed financing round, DiosCURE Therapeutics raised investments EUR 2.6 million from well-known venture capital firms and…
DiosCURE Therapeutics’ €2.6 Million Seed Financing Round


Gleiss Lutz advised DiosCURE Therapeutics on the deal. In the seed financing round, DiosCURE Therapeutics raised investments EUR 2.6 million from well-known venture capital firms and…
…